The literature review indicates distinct correlations between higher brain function impairments and specific DRP1 protein domains: encephalopathy and developmental regression were commonly observed in patients with pathogenic variants in the MD and GED domains, while peripheral neuropathy, ataxia, dystonia, and spasticity were more frequently associated with variants in the GTPase domain. Here, DNM1L is linked to Encephalopathy.